228 related articles for article (PubMed ID: 32296816)
1. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis.
Jasper AS; Musuuza JS; Tischendorf JS; Stevens VW; Gamage SD; Osman F; Safdar N
Clin Infect Dis; 2021 Jun; 72(11):1979-1989. PubMed ID: 32296816
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of fluoroquinolones versus macrolides for treatment of legionella pneumonia.
Kato H; Hagihara M; Asai N; Shibata Y; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Mar; 27(3):424-433. PubMed ID: 33268272
[TBL] [Abstract][Full Text] [Related]
3. Legionella pneumonia in hospitalized adults with respiratory failure: Quinolones or macrolides?
Ruiz-Spinelli A; Rello J
Eur J Intern Med; 2024 Feb; 120():62-68. PubMed ID: 37730517
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of empiric macrolides versus fluoroquinolones in community-acquired pneumonia associated with atypical bacteria: A meta-analysis.
Basilim A; Wali H; Rabaan AA; Eljaaly K
Respir Med Res; 2022 Nov; 82():100931. PubMed ID: 35905552
[TBL] [Abstract][Full Text] [Related]
6. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
[TBL] [Abstract][Full Text] [Related]
7. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.
Vardakas KZ; Siempos II; Grammatikos A; Athanassa Z; Korbila IP; Falagas ME
CMAJ; 2008 Dec; 179(12):1269-77. PubMed ID: 19047608
[TBL] [Abstract][Full Text] [Related]
8. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.
Choi SH; Cesar A; Snow TAC; Saleem N; Arulkumaran N; Singer M
Int J Antimicrob Agents; 2023 Sep; 62(3):106905. PubMed ID: 37385561
[TBL] [Abstract][Full Text] [Related]
9. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
[TBL] [Abstract][Full Text] [Related]
10. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.
Asadi L; Sligl WI; Eurich DT; Colmers IN; Tjosvold L; Marrie TJ; Majumdar SR
Clin Infect Dis; 2012 Aug; 55(3):371-80. PubMed ID: 22511553
[TBL] [Abstract][Full Text] [Related]
11. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
Lee JH; Kim HJ; Kim YH
J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
[TBL] [Abstract][Full Text] [Related]
12. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
14. Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis.
Sligl WI; Asadi L; Eurich DT; Tjosvold L; Marrie TJ; Majumdar SR
Crit Care Med; 2014 Feb; 42(2):420-32. PubMed ID: 24158175
[TBL] [Abstract][Full Text] [Related]
15. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
Brown RB; Iannini P; Gross P; Kunkel M
Chest; 2003 May; 123(5):1503-11. PubMed ID: 12740267
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
Vardakas KZ; Trigkidis KK; Falagas ME
Clin Microbiol Infect; 2017 Apr; 23(4):234-241. PubMed ID: 27965070
[TBL] [Abstract][Full Text] [Related]
17. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. The dilemma of monotherapy or combination therapy in community-acquired pneumonia.
Vardakas KZ; Trigkidis KK; Apiranthiti KN; Falagas ME
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027205
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for ventilator-associated pneumonia.
Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]